Our History

Pioneering
Innovation

Since its inception in 2011, SpiroChem has pioneered innovation, having built a reputation for handling some of the most complex and challenging chemistry in the life sciences. This innovation stems from SpiroChem’s namesake - original building molecules called ‘spirocycles.’

Wanting to be more than just a catalog company, SpiroChem has driven innovation across the drug discovery and process R&D chemistry value chain and has developed a deep, collective knowledge base that we call the ‘SpiroBrain.’

Building upon this, SpiroChem offers ‘best chance of being successful,’ tailoring innovative solutions to bring your portfolio to market faster. With headquarters in Basel, Switzerland and a second R&D site in Montreal, Canada, SpiroChem is uniquely positioned with close proximity to key life science hubs.

our history

Our journey begins

SpiroChem was founded as a spinoff from ETH Zürich, Switzerland, providing world-class chemistry libraries

SpiroChem 2.0

SpiroChem was awarded its first FTE contracts

Move to a global life science hub

The company relocated to a new site in Basel

Hitting milestones on the growth journey

SpiroChem opened its first toxicology lab, expanded its overall capacity, and branched into process research and development, as a global chemistry research partner

Futureproofing our offering

The company diversified into computational chemistry and AI

Becoming a transatlantic partner

SpiroChem acquired the company, Cyclenium Pharma, based in Montreal, Canada specializing in macrocycles

Strengthening scientific leadership

Gerhard Müller joins as CSO to kick start fully fledged medicinal chemistry and integrated drug discovery services

Stronger together

SpiroChem enters into strategic partnerships that enable fully integrated drug discovery, alongside an expansion of its industry-leading technology platforms